Inovio Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
INO Nasdaq 2830 www.inovio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Inovio Pharmaceuticals, Inc.

Inovio announces U.S. FDA accepted BLA for INO-3107 - Dec 30th, 2025 6:10 am
Sector Update: Health Care Stocks Edge Lower Monday Afternoon - Dec 29th, 2025 11:42 am
Top Midday Decliners - Dec 29th, 2025 11:02 am
Inovio Pharmaceuticals Says FDA Accepts Biologics License Application for INO-3107 for Standard Review; Shares Fall - Dec 29th, 2025 9:18 am
FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP) - Dec 29th, 2025 6:05 am
INOVIO Reports Inducement Grant Under Inducement Plan - Dec 19th, 2025 2:05 pm
INOVIO to Participate in December Investor Conferences - Nov 18th, 2025 6:05 am
Inovio (INO) Upgraded to Buy: Here's Why - Nov 14th, 2025 10:00 am
Individual investors invested in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) lost 13% last week, institutions remained on the sidelines - Nov 14th, 2025 4:37 am
INOVIO Announces Pricing of $25 Million Public Offering - Nov 11th, 2025 6:40 am
Inovio Pharmaceuticals Inc (INO) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ... - Nov 10th, 2025 10:00 pm
INOVIO Announces Proposed Public Offering - Nov 10th, 2025 4:09 pm
Oropharyngeal Cancer Market to Register Steady CAGR Throughout Forecast Period (2025-2034) Amid Shifting Treatment Paradigms | DelveInsight - Nov 10th, 2025 3:31 pm
Inovio: Q3 Earnings Snapshot - Nov 10th, 2025 2:17 pm
INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights - Nov 10th, 2025 2:05 pm
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults - Nov 3rd, 2025 6:05 am
INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025 - Oct 27th, 2025 6:05 am
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference - Oct 23rd, 2025 2:05 pm
Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine - Oct 21st, 2025 6:05 am
INOVIO to Participate in Upcoming Scientific Conferences - Sep 25th, 2025 6:05 am